SEARCH

SEARCH BY CITATION

References

  • Al-Ani B, Hansen KK, Hollenberg MD (2004). Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation. Mol Pharm 65: 149156.
  • Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2): S1S209.
  • Alvarez CE (2008). On the origins of arrestin and rhodopsin. BMC Evol Biol 8: 222.
  • Awasthi V, Mandal SK, Papanna V, Rao LVM, Pendurthi UR (2008). Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae. Arterioscler Thromb Vasc Biol 27: 14471455.
  • Bae JS, Yang L, Manithody C, Rezaie AR (2007a). The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor-1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells. Blood 110: 39093916.
  • Bae JS, Yang L, Rezaie AR (2007b). Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci USA 104: 28672872.
  • Blackburn JS, Brinckerhoff CE (2008). Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am J Pathol 173: 17361746.
  • Blackhart BD, Ruslim-Litrus L, Lu CC, Alves VL, Teng W, Scarborough RM et al. (2000). Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide. Mol Pharm 58: 11781187.
  • Bohm SK, Khitin LM, Grady EF, Aponte G, Payan DG, Bunnett NW (1996). Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. J Biol Chem 271: 2200322016.
  • Bonifacino JS, Traub LM (2003). Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395447.
  • Bonifacino JS, Hurley JH (2008). Retromer. Curr Opin Cell Biol 20: 427436.
  • Carlton J, Bujny M, Peter BJ, Oorschot VMJ, Rutherford A, Meller H et al. (2004). Sorting nexin-1 mediates tubular endosome-to-TGN transport through coincidence sensing of high curvature membranes and 3-phosphoinositides. Curr Biol 14: 17911800.
  • Chackalamannil S, Wang Y, Greenlee WJ, Hu Z, Xia Y, Ahn HS et al. (2008). Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J Med Chem 51: 30613064.
  • Chen CH, Paing MM, Trejo J (2004). Termination of protease-activated receptor-1 signaling by β-arrestins is independent of receptor phosphorylation. J Biol Chem 279: 1002010031.
  • Chen J, Ishii M, Wang L, Ishii K, Coughlin SR (1994). Thrombin receptor activation: confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem 269: 1604116045.
  • Chi L, Li Y, Stehno-Bittel L, Gao J, Morrison DC, Stechschulte DJ et al. (2001). Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J Interferon Cytokine Res 21: 231240.
  • Coughlin SR (2005). Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3: 18001814.
  • Coughlin SR, Camerer E (2003). PARticipation in inflammation. J Clin Invest 111: 2527.
  • Cullen PJ (2008). Endosomal sorting and signalling: an emerging role for sorting nexins. Nat Rev Mol Cell Biol 7: 574582.
  • Darmoul D, Gratio V, Devaud H, Labrurthe M (2004). Protease-activated receptor-2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor transactivation. J Biol Chem 279: 2029720934.
  • Daub H, Weiss FU, Wallasch C, Ullrich A (1996). Role of transactivation of the EGF receptor in signalling by G-protein coupled receptors. Nature 379: 557560.
  • DeFea KA, Zalevski J, Thoma MS, Dery O, Mullins RD, Bunnett NW (2000). β-Arrestin-dependent endocytosis of proteinase-activated receptor-2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 12671281.
  • Dery O, Thoma MS, Wong H, Grady EF, Bunnett NW (1999). Trafficking of proteinase-activated receptor-2 and β-arrestin-1 tagged with green fluorescent protein. J Biol Chem 274: 1852418535.
  • Drake MT, Shenoy SK, Lefkowitz RJ (2006). Trafficking of G protein-coupled receptors. Circ Res 99: 570582.
  • Edeling MA, Smith C, Owen D (2006). Life of a clathrin coat: insights from clathrin and AP structures. Nat Mol Cell Biol 7: 3244.
  • Feistritzer C, Riewald M (2005). Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine-1-phosphate receptor-1 crossactivation. Blood 105: 31783184.
  • Ferguson SS (2007). Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol Sci 28: 173179.
  • Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM et al. (2005). Activated protein C mediates novel lung endothelial barrier enhancement. J Biol Chem 280: 1728617293.
  • Furman MI, Krueger LA, Frelinger AL, 3rd, Barnard MR, Mascelli MA, Nakada MT et al. (2000a). GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood. Thromb Haemost 84: 492498.
  • Furman MI, Nurden P, Berndt MC, Nurden AT, Benoit SE, Barnard MR et al. (2000b). The cleaved peptide of PAR1 results in a redistribution of the platelet surface GPIb-IX-V complex to the surface-connected canalicular system. Thromb Haemost 84: 897903.
  • Ge L, Shenoy SK, Lefkowitz RJ, DeFea K (2004). Constitutive protease-activated-receptor-2 mediated migration of MDA-MB-231 breast cancer cells requires both β-arrestin-1 and 2. J Biol Chem 279: 5541955424.
  • Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T et al. (1994). The thrombin receptor's specificity for agonist peptide is defined by its extracellular surface. Nature 368: 648651.
  • Goldman PS, Nathanson NM (1994). Differential Role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor. J Biol Chem 269: 1564015645.
  • Goodman OB, Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW et al. (1996). Beta-arrestin acts as a clathrin adaptor in endocytosis of the Beta2-adrenergic receptor. Nature 383: 447450.
  • Gullapalli A, Wolfe BL, Griffin CT, Magnuson T, Trejo J (2006). An essential role for SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer, Hrs and Tsg101 independent functions of sorting nexins. Mol Biol Cell 17: 12281238.
  • Gurevich VV, Gurevich EV (2006). The structural basis of arrestin-mediated regulation of G protein-coupled receptors. Pharmacol Ther 110: 465502.
  • Han J, Liu G, Profirovic J, Niu J, Voyno-Yasenetskaya T (2009). Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor. FASEB J 12: 41934206.
  • Hanson MA, Stevens RC (2009). Discovery of new GPCR biology: one receptor structure at a time. Structure 17: 814.
  • Hanyaloglu AC, von Zastrow M (2008). Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537568.
  • Hasdemir B, Bunnett NW, Cottrell GS (2007). Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor 2 and calcitonin receptor-like receptor. J Biol Chem 282: 2964629657.
  • Hasdemir B, Murphy JE, Cottrell GS, Bunnett NW (2009). Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2. J Biol Chem 284: 2845328466.
  • Hein L, Ishii K, Coughlin SR, Kobilka BK (1994). Intracellular targeting and trafficking of thrombin receptors: a novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 269: 2771927726.
  • Hicke L, Riezman H (1996). Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell 84: 277287.
  • Hirsch JA, Schubert C, Gurevich V, Sigler PA (1999). The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97: 257269.
  • Ishii K, Hein L, Kobilka B, Coughlin SR (1993). Kinetics of thrombin receptor cleavage on intact cells: relation to signaling. J Biol Chem 268: 97809786.
  • Ishii K, Chen J, Ishii M, Koch WJ, Freedman NJ, Lefkowitz RJ et al. (1994). Inhibition of thrombin receptor signaling by a G protein-coupled receptor kinase. Functional specificity among G protein-coupled receptor kinases. J Biol Chem 269: 11251130.
  • Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF, Bunnett NW (2005). c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem 280: 1607616087.
  • Jala VR, Shao WH, Haribabu B (2005). Phosphorylation-independent beta-arrestin translocation and internalization of leukotriene B4 receptors. J Biol Chem 280: 48804887.
  • Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C et al. (2007). ‘Role reversal’ for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 12: 13031312.
  • Komarova YA, Mehta D, Malik AB (2007). Dual regulation of endothelial junctional permeability. Sci STKE 2007: re8.
  • Krupnick JG, Benovic JL (1998). The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38: 289319.
  • Kuliopulos A, Covic L, Seely SK, Sheridan PJ, Helin J, Costello CE (1999). Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38: 45724585.
  • Laporte S, Oakley RH, Zhang J, Holt JA, Ferguson SSG, Caron MG et al. (1999). The β2-adrenergic receptor/β-arrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 96: 37123717.
  • Lefkowitz RJ, Shenoy SK (2005). Transduction of receptor signals by β-arrestins. Science 308: 512517.
  • Lerner DJ, Chen M, Tram T, Coughlin SR (1996). Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271: 1394313947.
  • Lin CH, MacGurn JA, Chu T, Stefan CJ, Emr SD (2008). Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 135: 714725.
  • Lohse M, Benovic J, Codina J, Caron M, Lefkowitz R (1990). β-arrestin: a protein that regulates B-adrenergic receptor function. Science 248: 15471550.
  • Ludeman MJ, Zheng YW, Ishii K, Coughlin SR (2004). Regulated shedding of PAR1 N-terminal exodomain from endothelial cells. J Biol Chem 279: 1859218599.
  • Luo W, Wang Y, Hanck T, Stricker R, Reiser G (2006). Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activated protein-1. J Biol Chem 281: 79277936.
  • Luo W, Wang Y, Reiser G (2007). p24A, a type I transmembrane protein, controls ARF1-dependent resensitization of protease-activated receptor-2 by influence on receptor trafficking. J Biol Chem 282: 3024630255.
  • McLaughlin JN, Shen L, Holinstat M, Brooks JD, DiBenedetto E, Hamm HE (2005). Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem 280: 2504825059.
  • McLaughlin JN, Patterson MM, Malik AB (2007). Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 104: 56625667.
  • Mahajan VB, Pai KS, Lau A, Cunningham DD (2000). Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. Proc Natl Acad Sci USA 97: 1206212067.
  • Mannaioni G, Orr AG, Hamill CE, Yuan H, Pedone KH, McCoy KL et al. (2008). Plasmin potentiates synaptic N-methly-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1. J Biol Chem 283: 2060020611.
  • Marchese A, Paing MM, Temple BRS, Trejo J (2008). G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmcol Toxicol 48: 601629.
  • Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H et al. (2009). Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 284: 2884528855.
  • Molino M, Bainton DF, Hoxie JA, Coughlin SR, Brass LF (1997). Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation. J Biol Chem 272: 60116017.
  • Moore CAC, Milano SK, Benovic JL (2007). Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69: 19.1119.32.
  • Mosnier LO, Gale AJ, Yegneswaran S, Griffin JH (2004). Activated protein C variants with normal cytoprotective but reduced anticoagulant activity. Blood 104: 17401744.
  • Mosnier LO, Zlokovic BV, Griffin JH (2007). The cytoprotective protein C pathway. Blood 109: 31613172.
  • Mukherjee S, Gurevich VV, Preninger A, Hamm HE, Bader M-F, Fazleabas AT et al. (2002). Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2. J Biol Chem 277: 1791617927.
  • Nakanishi-Matsui M, Zheng YW, Weiss EJ, Sulciner D, Coughlin SR (2000). PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609613.
  • Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J et al. (2008). Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452: 654658.
  • Nikko E, Sullivan JA, Pelham HR (2008). Arrestin-like proteins mediate ubiquitination and endocytosis of the yeast metal transporter Smf1. EMBO Rep 9: 12161221.
  • O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS et al. (2000). Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 275: 1350213509.
  • Oldham WM, Hamm HE (2007). How do receptors activate G proteins? Adv Protein Chem 74: 6793.
  • Oldham WM, Hamm HE (2008). Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol 9: 6071.
  • Pai KS, Mahajan VB, Lau A, Cunningham DD (2001). Thrombin receptor signaling to cytoskeleton requires Hsp90. J Biol Chem 276: 3264232647.
  • Paing MM, Stutts AB, Kohout TA, Lefkowitz RJ, Trejo J (2002). β-arrestins regulate protease-activated receptor-1 desensitization but not internalization or down-regulation. J Biol Chem 277: 12921300.
  • Paing MM, Temple BRS, Trejo J (2004). A tyrosine-based sorting signal regulates intracellular trafficking of protease-activated receptor-1: multiple regulatory mechanisms for agonist-induced G protein-coupled receptor internalization. J Biol Chem 279: 2193821947.
  • Paing MM, Johnston CA, Siderovski DP, Trejo J (2006). Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization. Mol Cell Biol 28: 32213242.
  • Piper RC, Katzmann DJ (2007). Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23: 519547.
  • Pitcher J, Lohse MJ, Codina J, Caron MG, Lefkowitz RJ (1992). Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 31: 31933197.
  • Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C et al. (1999). EGF receptor transactivation by G protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884888.
  • Rallabhandi P, Nhu QM, Toshchakov VY, Piao W, Medvedev AE, Hollenberg MD et al. (2008). Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J Biol Chem 283: 2431424325.
  • Ramachandran R, Mihara K, Mathur M, Rochdi MD, Bouvier M, Defea K et al. (2009). Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways. Mol Pharmacol 76: 791801.
  • Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB et al. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 3812138138.
  • Ricks T, Trejo J (2009). Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization. J Biol Chem 284: 3444434457.
  • Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W (2002). Activation of endothelial cell protease activated receptor-1 by the protein C pathway. Science 296: 18801882.
  • Roosterman D, Schmidlin F, Bunnett NW (2003). Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor-2. Am J Physiol Cell Physiol 284: C1319C1329.
  • Rosenbaum DM, Rasmussen SG, Kobilka BK (2009). The structure and function of G-protein-coupled receptors. Nature 459: 356363.
  • Roth AF, Davis NG (1996). Ubiquitination of the yeast a-factor receptor. J Cell Biol 134: 661674.
  • Russo A, Soh JK, Paing MM, Arora P, Trejo J (2009a). Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc Natl Acad Sci USA 106: 63936397.
  • Russo A, Soh UJ, Trejo J (2009b). Proteases display biased agonism at protease-activated receptors: location matters! Mol Interv 9: 8796.
  • Scarborough RM, Naughton MA, Teng W, Hung DT, Rose J, Vu TK et al. (1992). Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267: 1314613149.
  • Schuepbach RA, Feistritzer C, Brass LF, Riewald M (2008). Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. Blood 111: 26672673.
  • Seminario-Vidal L, Kreda S, Jones L, O'Neal W, Trejo J, Boucher RC et al. (2009). Thrombin promotes release of ATP from lung epithelial cells through coordinated activation of Rho- and Ca2+-dependent signaling pathways. J Biol Chem 284: 2063820648.
  • Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL (2009). Modulating receptor function through RAMPs: can they represent drug targets in themselves? Drug Discov Today 14: 413419.
  • Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR (2000). Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 275: 2521625221.
  • Shi H, Rojas R, Bonifacino JS, Hurley JH (2006). The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain. Nat Struct Mol Biol 13: 540548.
  • Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR et al. (2005). Multiple independent functions of arrestins in regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharm 67: 110.
  • Tiruppathi C, Yan W, Sandoval R, Naqvi T, Pronin AN, Benovic JL et al. (2000). G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells. Proc Natl Acad Sci USA 97: 74407445.
  • Tobin AB, Butcher AJ, Kong KC (2008). Location, location, location … site specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 8: 413420.
  • Trejo J, Coughlin SR (1999). The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes vs recycling. J Biol Chem 274: 22162224.
  • Trejo J, Hammes SR, Coughlin SR (1998). Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc Natl Acad Sci USA 95: 1369813702.
  • Trejo J, Altschuler Y, Fu H-W, Mostov KE, Coughlin SR (2000). Protease-activated receptor downregulation: a mutant HeLa cell line suggests novel requirements for PAR1 phosphorylation and recruitment to clathrin-coated pits. J Biol Chem 275: 3125531265.
  • Trivedi V, Boire A, Tchernychev B, Kaneider NC, Leger AJ, O'Callaghan K et al. (2009). Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 137: 332343.
  • Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H et al. (2007). Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320: 113.
  • Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991a). Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 10571068.
  • Vu TK, Wheaton VI, Hung DT, Coughlin SR (1991b). Domains specifying thrombin-receptor interaction. Nature 353: 674677.
  • Wang Y, Zhou Y, Szabo K, Haft CR, Trejo J (2002). Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Mol Biol Cell 13: 19651976.
  • Wolfe BL, Marchese A, Trejo J (2007). Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J Cell Biol 177: 905916.
  • Wolfe BL, Trejo J (2007). Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic 8: 19.
  • Xia S, Dun XP, Hu PS, Kjaer S, Zheng K, Qian Y et al. (2008). Postendocytotic traffic of the galanin R1 receptor: a lysosomal signal motif on the cytoplasmic terminus. Proc Natl Acad Sci USA 105: 56095613.
  • Zania P, Gourni D, Aplin AC, Nicosia RF, Flordellis CS, Maragoudakis ME et al. (2009). Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis. J Pharmacol Exp Ther 328: 378389.